It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
JRSS’s FA Score shows that 0 FA rating(s) are green whileSNDA’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SNDA’s TA Score shows that 4 TA indicator(s) are bullish.
JRSS (@Medical/Nursing Services) experienced а -61.17% price change this week, while SNDA (@Medical/Nursing Services) price change was -12.35% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.60%. For the same industry, the average monthly price growth was -0.82%, and the average quarterly price growth was +1650.84%.
SNDA is expected to report earnings on Nov 13, 2024.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
JRSS | SNDA | JRSS / SNDA | |
Capitalization | 23.3M | 377M | 6% |
EBITDA | N/A | 55.2M | - |
Gain YTD | -64.886 | 133.849 | -48% |
P/E Ratio | 0.36 | 1.12 | 32% |
Revenue | N/A | 255M | - |
Total Cash | N/A | 4.08M | - |
Total Debt | 15.5K | 629M | 0% |
JRSS | SNDA | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 40 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 100 | |
PRICE GROWTH RATING 1..100 | 60 | 45 | |
P/E GROWTH RATING 1..100 | 99 | 17 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
JRSS's Valuation (92) in the null industry is in the same range as SNDA (97) in the Hospital Or Nursing Management industry. This means that JRSS’s stock grew similarly to SNDA’s over the last 12 months.
JRSS's Profit vs Risk Rating (100) in the null industry is in the same range as SNDA (100) in the Hospital Or Nursing Management industry. This means that JRSS’s stock grew similarly to SNDA’s over the last 12 months.
JRSS's SMR Rating (97) in the null industry is in the same range as SNDA (100) in the Hospital Or Nursing Management industry. This means that JRSS’s stock grew similarly to SNDA’s over the last 12 months.
SNDA's Price Growth Rating (45) in the Hospital Or Nursing Management industry is in the same range as JRSS (60) in the null industry. This means that SNDA’s stock grew similarly to JRSS’s over the last 12 months.
SNDA's P/E Growth Rating (17) in the Hospital Or Nursing Management industry is significantly better than the same rating for JRSS (99) in the null industry. This means that SNDA’s stock grew significantly faster than JRSS’s over the last 12 months.
SNDA | |
---|---|
RSI ODDS (%) | 2 days ago86% |
Stochastic ODDS (%) | 2 days ago75% |
Momentum ODDS (%) | 2 days ago78% |
MACD ODDS (%) | 2 days ago84% |
TrendWeek ODDS (%) | 2 days ago81% |
TrendMonth ODDS (%) | 2 days ago79% |
Advances ODDS (%) | 9 days ago78% |
Declines ODDS (%) | 2 days ago83% |
BollingerBands ODDS (%) | 2 days ago80% |
Aroon ODDS (%) | 3 days ago86% |
A.I.dvisor tells us that JRSS and GBCS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JRSS and GBCS's prices will move in lockstep.
Ticker / NAME | Correlation To JRSS | 1D Price Change % | ||
---|---|---|---|---|
JRSS | 100% | N/A | ||
GBCS - JRSS | 21% Poorly correlated | N/A | ||
SNDA - JRSS | 20% Poorly correlated | -5.32% | ||
LTGHY - JRSS | 3% Poorly correlated | -2.03% | ||
NVLPF - JRSS | 3% Poorly correlated | -7.65% | ||
ORPEF - JRSS | 0% Poorly correlated | N/A | ||
More |
A.I.dvisor indicates that over the last year, SNDA has been loosely correlated with ADUS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDA jumps, then ADUS could also see price increases.
Ticker / NAME | Correlation To SNDA | 1D Price Change % | ||
---|---|---|---|---|
SNDA | 100% | -5.32% | ||
ADUS - SNDA | 39% Loosely correlated | -2.10% | ||
OPCH - SNDA | 25% Poorly correlated | -2.98% | ||
NVLPF - SNDA | 21% Poorly correlated | -7.65% | ||
SGRY - SNDA | 21% Poorly correlated | -13.75% | ||
JRSS - SNDA | 20% Poorly correlated | N/A | ||
More |